The Food and Drug Administration (FDA) approved the AtriCure Synergy Ablation System for the treatment of persistent and longstanding persistent atrial fibrillation in patients undergoing another heart surgery. The Synergy bipolar radiofrequency clamp is the only surgical ablation device with FDA approval for afib treatment. Learn more: FDA Advisory Panel Recommends, and FDA Approves, Bipolar …
Read More
In follow up to our announcement yesterday of the Top Ten Atrial Fibrillation Videos of 2011, StopAfib.org now unveils the Top Ten Atrial Fibrillation Articles of 2011. Major topics of interest to the atrial fibrillation patient community this year were afib stroke prevention and the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for …
Read More
StopAfib.org has announced the Top Ten Atrial Fibrillation Videos of 2011. Afib stroke prevention again topped the list, with stories about warfarin (Coumadin), alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto), and the CHADS2 and CHA2DS2-VASc scoring tools for determining whether anticoagulants are needed. Other popular topics included sleep apnea, catheter ablation, and maze procedures (surgical …
Read More
Featured at Grand Rounds: Health Tips at USATODAY.com The holidays seem to bring on lots of atrial fibrillation, often attributed to a condition called "Holiday Heart Syndrome", which is supposedly caused by consuming too much alcohol and caffeine during the holidays. This year, can we avoid afib caused by Holiday Heart Syndrome? I think so, …
Read More
At the American Heart Association Scientific Sessions 2011, Dr. Sanjiv Narayan presented the high success rate of the FIRM trial of focal and rotor catheter ablation for atrial fibrillation. Watch the video at: Atrial Fibrillation Focal and Rotor Catheter Ablations Show High Success Rates — Video Interview with Dr. Sanjiv Narayan About the FIRM Trial
Read More
A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial …
Read More
At the American Heart Association Scientific Sessions 2011, Dr. John Mandrola presented a poster on gender-specific results of atrial fibrillation ablation in a private practice setting. In this video interview with him about the poster, he mentioned that in his experience women appear to be more challenging to treat with atrial fibrillation ablation and do …
Read More
Recently StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to chat live with two of their atrial fibrillation experts, Dr. Walid Saliba and Dr. David Van Wagoner, who were joined by StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts from the Cleveland Clinic …
Read More
An FDA advisory panel voted that the overall benefits outweighed the risks in afib ablations using the AtriCure Synergy bipolar radiofrequency clamp. This was based on the results of the ABLATE clinical trial for ablation of persistent or longstanding persistent atrial fibrillation during other heart surgery. The panel recommended that the FDA approve it, setting …
Read More
The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to …
Read More